Table 1. Patient Clinical Characteristics.
| Clinical Characteristic | Total Patients (n = 64) |
|---|---|
| Age (years) | 55.6 (± 13.9) |
| Sex | |
| Male | 39 (60.9) |
| Female | 25 (39.1) |
| Karnofsky performance scale | |
| < 70 | 8 (12.5) |
| ≥ 70 | 56 (87.5) |
| Genetic information | |
| Methylated MGMT promoter | |
| Negative | 23 (35.9) |
| Positive | 41 (64.1) |
| IDH mutation | |
| Mutant | 6 (9.4) |
| Wild type | 58 (90.6) |
| Tumor volume (mL) | |
| CEL | 111.9 (± 583.3) |
| NE-T2HSIL | 66.0 (± 42.2) |
Age and tumor volume are expressed as mean (± standard deviation); other variables are expressed as numbers (%). CEL = contrast-enhancing lesion, IDH = isocitrate dehydrogenase, MGMT = O6-methylguanine-DNA methyltransferase, NE-T2HSIL = non-enhancing T2 high signal intensity lesion